SNN · Smith & Nephew PLC
Market Cap
$11.26B
Shares
418.52M
Volume · Oct 2
1.23M
Avg daily vol (3M)
1.64M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$26.42
Open$26.34
Day$26.12–26.50
52W close$26.42–37.17
Avg vol 30d1.7M
Short int4.8M · 1.2% float · 2.2d
Short vol65%
Last earningsAug 4, 2026
DataJan 2020–Oct 2026
Up next
Next earnings call
Apr 7, 2027
Est · unconfirmed
· in 26 wks
call held Jun 30, 2025
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$6.30B
Trailing 12 months
Net income (TTM)
$635.00M
Trailing 12 months
Revenue growth YoY
+6.1%
Year over year
Operating margin
12.9%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.0%
Year over year · more shares
Price change (1Y)
-27.5%
Trailing year
Short interest
1.2%
Latest settlement · 2.2 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Low
Market backdrop
VIX 15.3 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−16%
below
Price vs 50-day avg
−9%
below
RSI (14)
30
neutral
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−8%
trailing
6-month return
−22%
trailing
YTD return
−19%
this year
Relative strength
−34%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $29 › 200d $31 — 200d above 50d
Institutional flow
Accumulating
4 of 295 funds reported for Sep 30 · net +526 sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.15% of float · ▼ -22.6% MoM · 2.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
295 holders — near 3-yr high, broad support
Squeeze score
47
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
28%
annualized · 1-yr
Max drawdown
−29%
past year
ATR
2.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Dec 31, 2025
2026
Revenue growth
Non-GAAP
6%
Trading profit growth
Non-GAAP
8%
Trading profit
Non-GAAP
$1.3B
Free cash flow
$800M
ROIC
Non-GAAP
at least 10%
China year-on-year profit decline
$15M – $20M
midterm
Return on invested capital
12% – 13%
by 2028
Free cash flow
Non-GAAP
at least $1B
Prior guidance
period ended
· from the Earnings Call filed Dec 31, 2025
China profit decline
· 2025
$50M – $60M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−16%
Bearish
Price vs 50-day avg
−9%
Bearish
RSI (14)
30
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $29 › 200d $31 — 200d above 50d
Institutional flow
Accumulating
4 of 295 funds reported for Sep 30 · net +526 sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.15% of float · ▼ -22.6% MoM · 2.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
295 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $26
Now $26 · 0%
Range high $37
vs 200-day avg -16%
vs 50-day avg -9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SNN
this stock
Smith & Nephew PLC
|
$11.26B | -19.5% | — | — | 1.2% |
|
ABT
Abbott Laboratories
|
$174.90B | -22.2% | +5.7% | 28.1 | 1.1% |
|
MDT
Medtronic plc
|
$113.38B | -10.1% | +8.4% | 21.8 | 1.3% |
|
SYK
Stryker Corp
|
$104.47B | -21.6% | +11.2% | 28.2 | 2.0% |
|
BSX
Boston Scientific Corp
|
$63.59B | -55.3% | +12.5% | 17.8 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SNN | -1.8% | -7.9% | -22.3% | -2.0% | -19.5% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | -1.6% | -7.5% | -34.5% | -2.9% | -32.3% |